T.Man Pharmaceutical PCL (BKK:TMAN)

Market Cap	4.44B
Revenue (ttm)	2.24B
Net Income (ttm)	433.10M
Shares Out	400.00M
EPS (ttm)	1.20
PE Ratio	9.26
Forward PE	9.06
Dividend	0.20 (1.80%)
Ex-Dividend Date	May 6, 2025

Volume	452,129
Average Volume	436,795
Open	11.00
Previous Close	11.10
Day's Range	11.00 - 11.50
52-Week Range	9.90 - 19.30
Beta	n/a
RSI	61.88
Earnings Date	May 9, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 944
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: TMAN

Financial Performance

In 2024, T.Man Pharmaceutical PCL's revenue was 2.23 billion, an increase of 12.42% compared to the previous year's 1.98 billion. Earnings were 450.70 million, an increase of 4.55%.